Aptevo Therapeutics Inc (APVO)
0.7616
+0.05
(+6.89%)
USD |
NASDAQ |
Apr 18, 16:00
0.7588
0.00 (0.00%)
After-Hours: 20:00
Aptevo Therapeutics Enterprise Value: -16.52M for April 17, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| April 17, 2024 | -16.52M |
| April 16, 2024 | -16.49M |
| April 15, 2024 | -16.49M |
| April 12, 2024 | -16.45M |
| April 11, 2024 | -16.39M |
| April 10, 2024 | -15.62M |
| April 09, 2024 | -15.16M |
| April 08, 2024 | -14.92M |
| April 05, 2024 | -14.97M |
| April 04, 2024 | -15.07M |
| April 03, 2024 | -14.88M |
| April 02, 2024 | -14.78M |
| April 01, 2024 | -14.64M |
| March 28, 2024 | -14.40M |
| March 27, 2024 | -14.74M |
| March 26, 2024 | -14.76M |
| March 25, 2024 | -14.76M |
| March 22, 2024 | -14.47M |
| March 21, 2024 | -14.51M |
| March 20, 2024 | -14.16M |
| March 19, 2024 | -14.22M |
| March 18, 2024 | -14.25M |
| March 15, 2024 | -14.01M |
| March 14, 2024 | -14.21M |
| March 13, 2024 | -14.26M |
| Date | Value |
|---|---|
| March 12, 2024 | -14.73M |
| March 11, 2024 | -14.56M |
| March 08, 2024 | -14.13M |
| March 07, 2024 | -13.38M |
| March 06, 2024 | -13.49M |
| March 05, 2024 | -13.87M |
| March 04, 2024 | -13.58M |
| March 01, 2024 | -13.05M |
| February 29, 2024 | -13.11M |
| February 28, 2024 | -13.43M |
| February 27, 2024 | -13.58M |
| February 26, 2024 | -13.72M |
| February 23, 2024 | -13.89M |
| February 22, 2024 | -13.80M |
| February 21, 2024 | -13.66M |
| February 20, 2024 | -13.69M |
| February 16, 2024 | -13.49M |
| February 15, 2024 | -13.40M |
| February 14, 2024 | -13.53M |
| February 13, 2024 | -13.51M |
| February 12, 2024 | -13.46M |
| February 09, 2024 | -13.41M |
| February 08, 2024 | -13.62M |
| February 07, 2024 | -13.49M |
| February 06, 2024 | -13.45M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-17.43M
Minimum
Sep 25 2023
200.70M
Maximum
Nov 11 2020
21.65M
Average
6.354M
Median
Enterprise Value Benchmarks
| Heron Therapeutics Inc | 510.51M |
| Creative Medical Technology Holdings Inc | -3.211M |
| BioSig Technologies Inc | 18.09M |
| Adial Pharmaceuticals Inc | 6.607M |
| IN8bio Inc | 23.30M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -5.903M |
| Total Expenses (Quarterly) | 6.384M |
| EPS Diluted (Quarterly) | -13.34 |
| Earnings Yield | -9.49K% |
| Normalized Earnings Yield | -35548.51 |